Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study
- 25 December 2010
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 22 (3) , 437-447
Abstract
Global genomic hypomethylation is a common epigenetic event in cancer that mostly results from hypomethylation of repetitive DNA elements. Case–control studies have associated blood leukocyte DNA hypomethylation with several cancers. Because samples in case–control studies are collected after disease development, whether DNA hypomethylation is causal or just associated with cancer development is still unclear.Keywords
This publication has 50 references indexed in Scilit:
- Blood leukocyte DNA hypomethylation and gastric cancer risk in a high‐risk Polish populationInternational Journal of Cancer, 2010
- Association between global DNA hypomethylation in leukocytes and risk of breast cancerCarcinogenesis, 2009
- Decline in genomic DNA methylation through aging in a cohort of elderly subjectsMechanisms of Ageing and Development, 2009
- Intra-individual Change Over Time in DNA Methylation With Familial ClusteringJAMA, 2008
- Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control studyThe Lancet Oncology, 2008
- Genomic Methylation of Leukocyte DNA in Relation to Colorectal Adenoma Among Asymptomatic WomenGastroenterology, 2008
- Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)Laboratory Investigation, 2007
- Hypermethylation of CpG island loci and hypomethylation of LINE‐1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological featuresThe Journal of Pathology, 2006
- The epigenetic progenitor origin of human cancerNature Reviews Genetics, 2006
- Initial sequencing and analysis of the human genomeNature, 2001